Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), administered as single agent in patients (pts) with colorectal cancer (CRC) refractory to standard regimens

被引：0
|
作者：
Rimassa, L. [1 ,2 ,3 ,4 ]
Sobrero, A. F. [1 ,2 ,3 ,4 ]
Santoro, A. [1 ,2 ,3 ,4 ]
Andretta, V. [1 ,2 ,3 ,4 ]
Gregorc, V. [1 ,2 ,3 ,4 ]
Sclafani, F. [1 ,2 ,3 ,4 ]
Caprioni, F. [1 ,2 ,3 ,4 ]
Caligaris-Cappio, F. [1 ,2 ,3 ,4 ]
Lambiase, A. [1 ,2 ,3 ,4 ]
Bordignon, C. [1 ,2 ,3 ,4 ]
机构：
[1] Inst Clin Humanitas, Rozzano, Italy
[2] Osped San Martino Genova, Genoa, Italy
[3] Ist Sci San Raffaele, Milan, Italy
[4] MolMed, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4088
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatment
    Miranda, Vanessa Costa
    Faria, Luiza Dib
    Freitas Melro Braghiroli, Maria Ignez
    Jacobs, Monica
    Sabbaga, Jorge
    Hoff, Paulo Marcelo
    Riechelmann, Rachel Pimenta
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [42] A PHASE II STUDY OF CEDIRANIB IN COMBINATION WITH MFOLFOX6 IN JAPANESE PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (CRC)
    Muro, K.
    Kato, T.
    Yamaguchi, K.
    Bando, H.
    Hazama, S.
    Amagi, K.
    Baba, H.
    Denda, T.
    Sakamoto, J.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 199 - 199
  • [43] A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens
    Krasner, C. N.
    McMeekin, D. S.
    Chan, S.
    Braly, P. S.
    Renshaw, F. G.
    Kaye, S.
    Provencher, D. M.
    Campos, S.
    Gore, M. E.
    BRITISH JOURNAL OF CANCER, 2007, 97 (12) : 1618 - 1624
  • [44] A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens
    C N Krasner
    D S McMeekin
    S Chan
    P S Braly
    F G Renshaw
    S Kaye
    D M Provencher
    S Campos
    M E Gore
    British Journal of Cancer, 2007, 97 : 1618 - 1624
  • [45] A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)
    Batist, G.
    Sawyer, M.
    Gabrail, N.
    Christiansen, N.
    Marshall, J. L.
    Spigel, D. R.
    Louie, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study
    Diaz-Rubio, E
    Sastre, J
    Zaniboni, A
    Labianca, R
    Cortes-Funes, H
    de Braud, F
    Boni, C
    Benavides, M
    Dallavalle, G
    Homerin, M
    ANNALS OF ONCOLOGY, 1998, 9 (01) : 105 - 108
  • [47] A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer
    Muro, K
    Hamaguchi, T
    Ohtsu, A
    Boku, N
    Chin, K
    Hyodo, I
    Fujita, H
    Takiyama, W
    Ohtsu, T
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 955 - 959
  • [48] A phase II study investigating cabozantinib in patients with refractory metastatic colorectal cancer (AGICC 17CRC01)
    Scott, Aaron James
    Cohen, Steven J.
    Mallick, Atrayee Basu
    Dotan, Efrat
    Gold, Philip Jordan
    Hochster, Howard S.
    Subramaniam, Somasundaram
    Barzi, Afsaneh
    Blatchford, Patrick Jud
    Messersmith, Wells A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [49] A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)
    Scott, Aaron J.
    Mallick, Atrayee Basu
    Dotan, Efrat
    Cohen, Steven J.
    Gold, Philip J.
    Hochster, Howard S.
    Subramaniam, Somasundaram
    Barzi, Afsaneh
    Watts, George S.
    Blatchford, Patrick J.
    Messersmith, Wells A.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (10): : 1188 - 1196
  • [50] A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience
    Engel, Ryan H.
    Brown, Jennifer A.
    Von Roenn, Jamie H.
    O'Regan, Ruth M.
    Bergan, Raymond
    Badve, Sunil
    Rademaker, Alfred
    Gradishar, William J.
    CANCER INVESTIGATION, 2007, 25 (08) : 733 - 737
12345